Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Sarkar

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Pancreas|November 5, 1999
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinomaR M Mohammad, Y Li, A N Mohamed, et al.
Pancreas|April 1, 1997
HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survivalM C Dugan, S T Dergham, R Kucway, et al.
The Journal of Biological Chemistry|April 22, 1994
c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activityF H Sarkar, M R Smith, T Hoover, et al.
Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Genistein potentiates the radiation effect on prostate carcinoma cellsG G Hillman, J D Forman, O Kucuk, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1995
A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissueF H Sarkar, M Valdivieso, J Borders, et al.
Human Pathology|June 19, 2001
Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephromaC R Pierson, M S Schober, T Wallis, et al.
Cancer|August 1, 1997
The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinomaS T Dergham, M C Dugan, U S Joshi, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomyO Kucuk, F H Sarkar, W Sakr, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Pancreas|November 5, 1999
Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinomaR M Mohammad, Y Li, A N Mohamed, et al.
Pancreas|April 1, 1997
HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survivalM C Dugan, S T Dergham, R Kucway, et al.
The Journal of Biological Chemistry|April 22, 1994
c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activityF H Sarkar, M R Smith, T Hoover, et al.
Oncogene|September 7, 2010
MI-219-zinc combination: a new paradigm in MDM2 inhibitor-based therapyA S Azmi, P A Philip, F W J Beck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Genistein potentiates the radiation effect on prostate carcinoma cellsG G Hillman, J D Forman, O Kucuk, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1995
A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissueF H Sarkar, M Valdivieso, J Borders, et al.
Human Pathology|June 19, 2001
Mixed epithelial and stromal tumor of the kidney lacks the genetic alterations of cellular congenital mesoblastic nephromaC R Pierson, M S Schober, T Wallis, et al.
Cancer|August 1, 1997
The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinomaS T Dergham, M C Dugan, U S Joshi, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomyO Kucuk, F H Sarkar, W Sakr, et al.
Pageof 13